Studying elecoglipron for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a new medicine called elecoglipron, taken alone or with another diabetes drug (dapagliflozin), to see if it helps control blood sugar better than a placebo. It may be an option if your current treatment isn't working well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for at least 90 days.
- Your diabetes is not well controlled with diet and exercise alone or with your current medications.
- Your average blood sugar level (HbA1c) is between 7% and 10.5%.
- Your body mass index (BMI) is 23 or higher.
- Your weight has been stable for the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This study tests an experimental diabetes pill (elecoglipron) to see if it works as well as a current medicine, semaglutide, for people with type 2 diabetes who also have heart risk factors. It aims to help better control blood sugar and weight.
This trial tests a new medicine called elecoglipron to see if it helps control blood sugar in people with type 2 diabetes who also have reduced kidney function. You would continue taking your current SGLT2i medication (like dapagliflozin).
This trial tests a new once-daily tablet (elecoglipron) against a placebo to see if it can help improve blood sugar control in adults with type 2 diabetes who are already on insulin. It may offer an additional treatment option to help manage your diabetes.
This Phase 3 study tests whether LID104 can improve blood sugar control and safety in people with type 2 diabetes who are not meeting their A1c goal on metformin. You may benefit if your diabetes is still too high despite diet, exercise, and the usual metformin dose.
This trial tests an investigational drug called elecoglipron to see if it helps people with obesity or overweight lose weight. It may be an option if you have a high body mass index or weight-related health issues like high blood pressure or prediabetes.
Hear when a new Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.